论文部分内容阅读
临床资料自1979年以来,我们对88例慢性乙型肝炎(下称慢乙肝)患者分別应用HBsAg特异性免疫核糖核酸(HBsAg iRNA、猪胸腺素(TP)、转移因子(TF)等药物进行了治疗观察,现报告如下。一、一般资料: 88例全部为慢乙肝。其中慢性活动性肝炎(下称慢活肝)为38例(占43.2％),慢性迁延性肝炎为50例(占56.8％),黄疸型为25例(占28.5％),无黄疸型为63例(占71.5％)。病人来自本院门诊,除HBs Ag iRNA组21例于门诊治疗观察外,其余均收入院进行治疗。
Clinical Data Since 1979, 88 cases of chronic hepatitis B (hereinafter referred to as chronic hepatitis B) were treated with HBsAg-specific immunosorbent RNA (HBsAg iRNA, porcine thymosin (TP), transfer factor (TF) and other drugs The treatment of the report, the report is as follows.A general information: 88 cases of chronic hepatitis B. Of which chronic active hepatitis (hereinafter referred to as slow living liver) was 38 cases (43.2%), chronic persistent hepatitis was 50 cases (56.8 %), Jaundice was 25 (28.5%), jaundice was 63 (71.5%) .The patients came from our hospital, except for HBs Ag iRNA group of 21 cases outpatient treatment observation, the rest were admitted to the hospital treatment.